BioRestorative Therapies (NASDAQ: BRTX), a life sciences company focused on adult stem cell-based therapies, announced the pricing of the underwritten public offering of 2,300,000 units, each consisting of one share of its common stock and a warrant to purchase one share of its common stock at a per unit price of $10.00. According to the update, the warrants have a per share exercise price of $10.00, are exercisable immediately and expire five years from the date of issuance. As a result of the offering, the company’s common stock began trading under the ticker symbol BRTX on the Nasdaq Capital Market on Nov. 5, 2021. The offering closed on Nov. 9, 2021. In addition, BioRestorative Therapies granted to the underwriters a 45-day option to purchase up to 345,000 additional shares and/or warrants to purchase up to 345,000 shares of common stock to cover over-allotments, if any. Roth Capital Partners acted as sole manager for the offering.
To view the full press release, visit https://ibn.fm/5d3BT
About BioRestorative Therapies Inc.
BioRestorative Therapies develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The company’s two core programs, brtxDISC(TM) and ThermoStem(R), relate to the treatment of disc/spine disease and metabolic disorders. For more information about the company, visit www.BioRestorative.com.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.